04:28 PM EDT, 05/22/2024 (MT Newswires) -- Reshma Kewalramani, Director, CEO & President, on May 20, 2024, sold 15,202 shares in Vertex Pharmaceuticals ( VRTX ) for $6,795,294. Following the Form 4 filing with the SEC, Kewalramani has control over a total of 121,374 shares of the company, with 121,374 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532024000156/xslF345X03/wk-form4_1716409296.xml

Price: 447.92, Change: +0.39, Percent Change: +0.09